M.E.D.U.S.A. Scalper Indicator

Editor's note: Our friend Teeka Tiwari is back with an idea so big, he's calling it his next "trillion-dollar trade." Read on for the details... Dear reader, Rolling Stone magazine calls it a "miracle." The New York Times calls it a "revolution." Even the FDA calls one drug in this trillion-dollar opportunity a "breakthrough." I'm talking about a new branch of human medicine potentially worth trillions every year. And based on my months of intensive research... international travel... and meeting with the top expert in this new trillion-dollar space... I believe this single trade could let you pull down 100 years of average stock market returns in 18 months. Because this breakthrough offers hope to the 2.7 million registered Vietnam war vets struggling with PTSD... And the 650,000 Gulf War Vets here in America... And the 1.9 million vets who served in Iraqi Freedom and Enduring Freedom... And the billion or so people worldwide living with a mental health disorder. I believe this single event is enough to change your life for the better. Like my followers were able to do with my first two trillion-dollar trades: Apple in 2003 and crypto in 2016. So what is this new breakthrough? And how could it hand you a century's worth of average stock gains in the next 18 months? Click here now for all the details. Regards, Teeka Tiwari P.S. Be ready to take swift action. The tiny stock I reveal around the halfway mark could see 10x gains from here, easily. Again, click here for the full story. All contents of this e-mail are copyright 2021 by Empire Financial Research. All rights reserved. Reproducing any part of this document is prohibited without the express written consent of Whitney Tilson. Protected by U.S. Copyright Law {Title 17 U.S.C. Section 101 et seq., Title 18 U.S.C. Section 2319}: Infringements can be punishable by up to five years in prison and $250,000 in fines. DISCLAIMER: The work included in this publication is based on SEC filings, current events, interviews, and corporate press releases. It may contain errors, and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility. The views expressed in this publication do not necessarily reflect the views of Empire Financial Research. You're receiving this email at diansastroxz.forex@blogger.com. If you have any questions about your subscription, or would like to change your email settings, please contact Empire Financial Research at (800) 961-2618 (US) or (646) 609-8709 (international) Monday-Friday between 9:00 a.m. and 5:00 p.m. Eastern Time. Empire Financial Research, 601 Lexington Ave, 20th Floor New York, NY 10022. If you wish to contact us by email, please do not reply to this message but instead go to info@empirefinancialresearch.com. To unsubscribe from email messages like these, please click here.